Treatment

Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.

Published:

Mantle Cell Lymphoma News From ASH 2018: Treatment Research Updates

On-site in San Diego at the 2018 American Society of Hematology (ASH) annual meeting, Patient Power founder Andrew Schorr is joined by renowned expert Dr. Peter Martin to discuss highlights in mantle cell lymphoma treatment news.

Published:

ASH 2018 Daily Wrap: MPN News

On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

An Evolving Treatment Landscape: Mantle Cell Lymphoma Treatment and Research News From an Expert

Noted expert Dr. Stephen Douglas Smith joined Patient Power to share promising advances being made in therapies for mantle cell lymphoma. Watch now to stay up-to-date with the latest treatment and research news.

Published:

Non-Hodgkin Lymphoma Updates From an Expert

Dr. Joshua Brody from Mount Sinai School of Medicine joined Patient Power to provide an important update in non-Hodgkin lymphoma research. Have new avenues in treatment been created? Watch now to stay informed with current treatment and research news.

Published:

The Latest in Non-Hodgkin Lymphoma News From ASCO

Dr. John Leonard from Weill Cornell Medicine joined Patient Power to provide an update on the latest research news in non-Hodgkin lymphoma coming from major medical conferences around the world. Dr. Leonard provides an overview of the news including and explanation of the results of the RELEVANCE study and addresses CAR T-cell therapy.

Published:

Nuevos Tratamientos Para Pacientes de Linfoma del Manto (ASH 17)

El linfoma del manto representa un 6% de todos los linfomas. En el congreso de la Sociedad Americana de Hematología (ASH) se han presentado varios estudios que confirman la eficacia de los nuevos tratamientos para estos pacientes.

Published:

Which Types of Cancer Patients Can Benefit From CAR T-Cell Therapy?

What type of cancer patients can benefit from CAR T-cell therapy? Esther Schorr sits down with expert Dr. Jon Arnason at the ASH 2017 conference to discuss how CAR T-cell therapy is currently used in blood cancers.

Published:

CAR T-Cell Therapy Update From ASH 2017

Which CAR T-cell treatments are currently approved for cancer treatment? Watch now to hear an update from ASH 2017 with Dr. David Maloney.

Published:

Showing 9 of 25 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 22, 2018